跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
吸入用丙酸倍氯米松混悬液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Beclometasone Dipropionate Suspension for Inhalation
Approved
化学药品
Beclometasone Dipropionate Suspension for Inhalation
CHIESI FARMACEUTICI S.P.A.
🇨🇳 National Medical Products Administration
Approval Date
Feb 14, 2023
Approval ID
8TEKuKkf5ID
Company
CHIESI FARMACEUTICI S.P.A.
Type
化学药品
Approval Details
Approval Id
8TEKuKkf5ID
Approval Number
国药准字HJ20130214
Generic Name
吸入用丙酸倍氯米松混悬液
Generic Name En
Beclometasone Dipropionate Suspension for Inhalation
Drug Type
化学药品
Dosage Form
吸入混悬剂
Strength
2ml：0.8mg
Reg Date
2023-02-14
Expired Date
2028-02-13
Company Name
CHIESI FARMACEUTICI S.P.A.
Production Company Name
CHIESI FARMACEUTICI S.P.A.
Company Detail Path
/organization/chiesi-farmaceutici-s-p-a
Production Company Detail Path
/organization/chiesi-farmaceutici-s-p-a
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 14, 2023
Approval ID
8TEKuKkf5ID
Type
化学药品
Back to NMPA Approvals
